한글목차

세계의 한랭 요법 시장 규모는 2024년에 223억 달러에 달하며, 2032년에는 345억 8,000만 달러에 달할 것으로 예측되며, 예측 기간인 2024-2032년의 CAGR은 5.6%로 성장할 전망입니다.

냉찜질은 섬유근육통, 요통 등 여러 만성질환을 치료하는 데 도움이 됩니다. 통증 증상 관리를 돕고 일시적인 완화를 제공합니다. 냉찜질은 일반적으로 연조직 손상의 급성기에 사용됩니다. 얼음이나 냉동 커프를 사용하여 연조직 손상 부위를 냉각시킵니다.

시장 역학:

촉진요인과 억제요인

스포츠 부상 증가

스포츠 부상 증가는 냉찜질 치료 시장 수요를 증가시킬 것으로 예상됩니다. 스포츠 부상의 빈도가 증가함에 따라 통증 관리 치료에 대한 수요도 증가할 것입니다. 냉찜질은 염좌, 타박상, 근육 경직으로 인한 염증, 부종 및 불편함을 줄이는 효과적인 방법으로 확립되었습니다. 이 치료법은 운동선수들이 더 빨리 회복하고 훈련과 경기에 더 빨리 복귀할 수 있도록 돕기 위해 자주 사용되고 있습니다. 따라서 쉽게 구할 수 있는 냉찜질 제품에 대한 수요가 증가하고 있습니다. 프로 선수들이 냉찜질 요법을 사용하면서 냉찜질에 대한 인식이 높아졌고, 초보자들도 냉찜질에 대한 인식이 높아지면서 냉찜질에 대한 관심이 높아졌습니다.

냉찜질은 운동 후 근육의 재활을 돕고 장기적인 부상을 피하기 위해 활용될 수 있습니다. 부상 증가로 인해 냉찜질에 대한 수요가 증가하고 있습니다. 예를 들어 호주 보건 복지 연구소가 발표한 2021-2022년 보고서에 따르면 아동 및 청소년의 스포츠, 운동, 레크리에이션 활동과 관련된 부상으로 인한 입원 건수는 약 18,700건(21%)으로, 10-12세, 13-15세 아동의 부상 입원 3건 중 1건 이상이 스포츠와 관련된 것으로 나타났습니다. 스포츠와 관련이 있습니다.

인식 부족

냉찜질 요법에 대한 인식 부족은 시장 성장의 주요 억제요인입니다. 많은 사람들이 냉찜질이 통증 관리에 효과적이라는 사실을 알지 못해 시판되는 진통제와 같은 표준 치료에 의존하거나 통증을 무시하고 있습니다. 이로 인해 시장 침투가 제한되어 사람들이 냉찜질 요법의 잠재적인 혜택을 누리지 못하고 있습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 개요

제4장 시장 역학

• 영향요인
  • 촉진요인
    • 스포츠 상해의 증가
  • 억제요인
    • 인식의 부족
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter's Five Forces 분석
• 공급망 분석
• 가격 분석
• 특허 분석
• 규제 분석
• SWOT 분석
• 미충족 요구

제6장 제품별

• OTC 제품
  • 크림
  • 젤
  • 패치
  • 기타 OTC 제품
• 처방전 제품
  • 전동 디바이스
  • 비전동 디바이스

제7장 용도별

• 스포츠 의학
• 수술후 요법
• 외상과 정형외과
• 기타

제8장 유통 채널별

• 소매 약국
• 원내 약국
• E-Commerce

제9장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 스페인
  • 이탈리아
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제10장 경쟁 구도

• 경쟁 시나리오
• 시장 현황·점유율 분석
• M&A 분석

제11장 기업 개요

• Breg, Inc.
  • 회사 개요
  • 제품 포트폴리오
    • 제품 설명
    • 제품의 핵심성과지표(KPI)
    • 실적 및 예측 제품 판매
    • 제품 판매량
  • 재무 개요
    • 기업 매출
    • 지역별 매출 점유율
    • 매출 예측
  • 주요 발전
    • 합병과 인수
    • 주요 제품 개발 활동
    • 규제기관의 승인 등
  • SWOT 분석
• Brownmed, Inc.
• Cardinal Health
• Enovis Corporation
• Ossur hf.
• Performance Health Supply, Inc.
• Medline Industries, LP
• Compass Health Brands Corp
• Romsons Scientific & Surgical Pvt. Ltd
• Bird & Cronin, LLC.
• GSK plc
  • 파이프라인 제품의 설명
  • 제품의 핵심성과지표(KPI)
  • 주요 활동
  • 시장 참여 타임라인
  • 제품 보급률
  • 판매 추정과 예측
• Takeda Pharmaceutical Company Limited
• Poseida Therapeutics
• Regeneron Pharmaceuticals, Inc.
• Genentech, Inc.

제12장 부록

영문목차

The global Cold Pain Therapy market reached US$ 22.3 billion in 2024 and is expected to reach US$ 34.58 billion by 2032, growing at a CAGR of 5.6% during the forecast period 2024-2032.

Cold therapy helps in treating several chronic problems, including fibromyalgia and back pain. It can assist in managing pain symptoms and offer momentary relief. Cold therapy is usually used in the acute stage of a soft tissue injury. It involves the use of ice or a cryocuff to cool down a damaged area of soft tissue following an injury.

Market Dynamics: Drivers & Restraints

The Increasing Incidence of Sports Injuries

The increasing number of sports injuries is expected to increase the demand for cold pain therapy market. As the frequency of sports injuries rises, the demand for pain management treatments increases. Cold treatment is a well-established, effective method for reducing inflammation, swelling, and discomfort caused by sprains, strains, and muscular stiffness, which are all frequent sports injuries. This treatment is frequently used by athletes to speed up their recovery and allow them to return to training or competition earlier. This creates a demand for easily available cold therapy products. Professional athletes' increasing use of cold therapy promotes awareness and inspires beginners to follow similarly.

Cold treatment can also be utilized to aid with post-workout muscle rehabilitation and avoid long-term injury. There is an increasing number of injuries which are increasing the demand for cold pain therapy. For instance, according to the report published by the Australian Institute of Health and Welfare in 2021-22, around 18,700 injury hospitalisations among children and adolescents that involved sport, exercise or recreational activities (21%). Over 1 in 3 injury hospitalisations for children aged 10-12 and 13-15 involved sports

Lack of awareness

Lack of awareness of cold pain therapy is a major impediment to market growth. Many people are unaware of cold therapy as a legitimate pain management option, so they rely on standard treatments such as over-the-counter pain relievers or simply ignore the pain. This limits market penetration and keeps individuals from receiving the potential benefits of cold treatment.

Segment Analysis

The global cold pain therapy market is segmented based on product, application, distribution channel, and region.

Type:

Over-the-counter products segment is expected to dominate the global cold pain therapy market share

Over-the-counter products are widely available in pharmacies, supermarket stores, and online sellers. Because of their ease of access, they are the preferred choice for persons who are experiencing minimal pain.

Consumers can acquire OTC products without a doctor's visit or prescription, saving them time and effort. OTC drugs enable the self-treatment of minor pain, empowering people to manage their discomfort without having to rely on healthcare specialists every time. A large number of patches, cooling gels are being getting traction due to the increasing number of sports injuries and the due to the increased costs of prescribed therapies.

Geographical Analysis

North America is expected to hold a significant position in the global cold pain therapy market share

North America is expected to hold a dominant position in the market share this is due to the region holding a significant number of leading POCT device manufacturers and diagnostics companies.

North America has a well-developed healthcare infrastructure and comprehensive insurance coverage. This increases access to advanced pain management choices, such as cold therapy treatments. Furthermore, coverage for cold therapy-based rehabilitation therapies has the potential to increase demand for cold therapy devices.

The region's culture values physical activity and engagement in sports. This increases the occurrence of sports injuries such as sprains, strains, and muscle soreness, resulting in a strong demand for cold treatment products for pain relief and recovery. The companies are increasingly entering into strategic collaborations and partnerships that increases the market growth in the region. For instance, in March 2023, Aspen Medical Products (Aspen)and NICE Recovery Systems (NICE) announced a strategic partnership that aims to bring more precise recovery and pain management solutions to patients and medical professionals alike. The partnership leverages NICE's advanced cold compression technology with Aspen's effective bracing solutions to deliver pain management and post-operative care to patients recovering from surgery or injury.

Competitive Landscape

The major global players in the cold pain therapy market include Breg, Inc., Brownmed, Inc., Cardinal Health, Enovis Corporation, Ossur hf., Performance Health Supply, Inc., Medline Industries, LP, Compass Health Brands Corp, Romsons Scientific & Surgical Pvt. Ltd and Bird & Cronin, LLC. among others.

Key Developments

• In June 2024, Moov launched 'Moov Cool'. The new product has been designed to offer relief from muscle and joint pain due to injuries, sprains, strains and muscle soreness associated with an active lifestyle by infusing with the cooling power of menthol.
• In March 2023, HealthMe announced a new partnership with Breg to launch a patient direct-pay solution for orthopedic cold therapy Products. HealthMe and Breg, Inc. launched a direct-pay eCommerce engine that will enable orthopedic providers to easily capture patient payments for the company's line of cold therapy devices. Breg selected HealthMe to power the eCommerce engine.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Cold Pain Therapy Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Application
• 3.3. Snippet by Distribution Channel
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The Increasing Incidence of Sports Injuries
  • 4.1.2. Restraints
    • 4.1.2.1. Lack of Awareness
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Product

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. OTC Products*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Creams
  • 6.2.4. Gels
  • 6.2.5. Patches
  • 6.2.6. Other OTC Products
• 6.3. Prescription Products
  • 6.3.1. Motorized Devices
  • 6.3.2. Non-Motorized Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 7.1.2. Market Attractiveness Index, By Application
• 7.2. Sports Medicine*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Post-operative Therapies
• 7.4. Trauma and Orthopedic
• 7.5. Other

8. By Distribution Channel

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 8.1.2. Market Attractiveness Index, By Distribution Channel
• 8.2. Retail Pharmacies*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Hospital Pharmacies
• 8.4. E-commerce

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. U.K.
    • 9.3.6.3. France
    • 9.3.6.4. Spain
    • 9.3.6.5. Italy
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

• 11.1. Breg, Inc.*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. Brownmed, Inc.
• 11.3. Cardinal Health
• 11.4. Enovis Corporation
• 11.5. Ossur hf.
• 11.6. Performance Health Supply, Inc.
• 11.7. Medline Industries, LP
• 11.8. Compass Health Brands Corp
• 11.9. Romsons Scientific & Surgical Pvt. Ltd
• 11.10. Bird & Cronin, LLC.
• Similar data will be provided for each market player.

Emerging Market Players

• 11.11. GSK plc*
  • 11.11.1. Pipeline Products Description
  • 11.11.2. Product Key Performance Indicators (KPIs)
  • 11.11.3. Key Activities
  • 11.11.4. Market Entry Timelines
  • 11.11.5. Product Penetration Rate
  • 11.11.6. Sales Estimation and Projections
• 11.12. Takeda Pharmaceutical Company Limited
• 11.13. Poseida Therapeutics
• 11.14. Regeneron Pharmaceuticals, Inc.
• 11.15. Genentech, Inc.
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us